You've never been right once about anything Ocata related. But you sure are entertaining at times!
Celgene and Juno Announce Ten-Year Collaboration to Advance Potentially Groundbreaking Immunotherapies for Patients with Cancer and Autoimmune Diseases
Broad strategic collaboration leveraging combined immunology expertise and assets to develop and commercialize novel immunotherapies for the treatment of cancer and autoimmune diseases
Celgene gains option to commercialize Juno programs outside North America and co-promote certain programs globally
Juno gains option to co-develop and co-promote select Celgene programs
Celgene to make initial payment of approximately $1 billion which includes the purchase of ~9.1 million shares of Juno stock at $93.00 per share, with potential to increase its stake over time
Perhaps you show go and see when the FDA CBER Advisory Comittee meets re: SPA/cellular.
She's just too stupid and knows nothing about the market and investing, She took her family fortune and put it all on Ocata years ago buying 250 shares at $.29/shr thinking she was going to get rich overnight. Not. What a dope that Keep_The WelfareClosetQueen is.